dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Planas Vilaseca, Alejandra |
dc.contributor.author | Simó Servat, Olga |
dc.contributor.author | Hernández Pascual, Cristina |
dc.contributor.author | Ortiz Zuñiga, Angel Michael |
dc.contributor.author | Herance Camacho, José Raul |
dc.contributor.author | Ferreira González, Ignacio |
dc.contributor.author | Simó Canonge, Rafael |
dc.contributor.author | Marsal Mora, Josep Ramon |
dc.date.accessioned | 2022-06-15T12:53:23Z |
dc.date.available | 2022-06-15T12:53:23Z |
dc.date.issued | 2021-12 |
dc.identifier.citation | Planas A, Simó-Servat O, Hernández C, Ortiz-Zúñiga Á, Marsal JR, Herance JR, et al. Diabetic Retinopathy and Skin Tissue Advanced Glycation End Products Are Biomarkers of Cardiovascular Events in Type 2 Diabetic Patients. J Pers Med. 2021 Dec;11(12):1344. |
dc.identifier.issn | 2075-4426 |
dc.identifier.uri | https://hdl.handle.net/11351/7689 |
dc.description | Biomarcadores de enfermedades cardiovasculares; Complicaciones de la diabetes; Diabetes tipo 2 |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Journal of Personalized Medicine;11(12) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Retinopatia diabètica |
dc.subject | Glicosilació |
dc.subject | Cor - Malalties - Factors de risc |
dc.subject.mesh | Diabetic Retinopathy |
dc.subject.mesh | Glycation End Products, Advanced |
dc.subject.mesh | Cardiovascular Diseases |
dc.subject.mesh | /diagnosis |
dc.title | Diabetic Retinopathy and Skin Tissue Advanced Glycation End Products Are Biomarkers of Cardiovascular Events in Type 2 Diabetic Patients |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/jpm11121344 |
dc.subject.decs | retinopatía diabética |
dc.subject.decs | productos finales de la glicación avanzada |
dc.subject.decs | enfermedades cardiovasculares |
dc.subject.decs | /diagnóstico |
dc.relation.publishversion | https://doi.org/10.3390/jpm11121344 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Planas A, Simó-Servat O, Hernández C, Ortiz-Zúñiga Á, Simó R] Unitat de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Spanish Institute of Health (ISCIII), 28029 Madrid, Spain. [Marsal JR, Ferreira-González I] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER en Epidemiología y Salud Pública (CIBERESP), Spanish Institute of Health (ISCIII), 28029 Madrid, Spain. [Hernández C] Grup de Recerca en Imatge Molecular Mèdica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Medicina Nuclear, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBBIM-Nanomedicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBERBBN, Spanish Institute of Health (ISCIII), 28029 Madrid, Spain |
dc.identifier.pmid | 34945815 |
dc.identifier.wos | 000738266800001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |